MC
MESO

Moors & Cabot’s Mesoblast MESO Stock Holding History

Moors & Cabot’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,566
Closed -$67K – 900
2021
Q2 		$67K Buy
+22,566
New +$354K ﹤0.01% 785

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return

Moors & Cabot's MESO Position: Q3 2021 in Review

Moors & Cabot sold out of Mesoblast (MESO) in Q3 2021, closing a stake of 22,566 shares — an estimated $67K sold.

Moors & Cabot first reported a position in MESO in Q2 2021 and held it in 1 quarter. The position peaked at $67K in Q2 2021. 41 funds tracked by Wall St. Rank hold MESO as of Q3 2021.

  • Moors & Cabot reported no remaining Mesoblast position as of Q3 2021 after selling out during the quarter.
  • Moors & Cabot sold 22,566 Mesoblast shares in Q3 2021, an estimated $67K.
  • Moors & Cabot first reported a position in Mesoblast in Q2 2021 and held it in 1 quarter.
  • Moors & Cabot's Mesoblast position peaked at $67K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Mesoblast as of Q3 2021.

Based on Moors & Cabot's 13F filing for Q3 2021, filed 5 Nov 2021.